(Q32139406)

6 July 2017

1 reference

title

Bisphosphonates for the relief of pain secondary to bone metastases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6483200&resulttype=core&format=json

14 May 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6483200&resulttype=core&format=json

14 May 2020

Philip J Wiffen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6483200&resulttype=core&format=json

14 May 2020

author name string

R Wong

series ordinal

1

1 reference

6 July 2017

P J Wiffen

series ordinal

2

1 reference

6 July 2017

language of work or name

1 reference

1 January 2002

1 reference

Cochrane Database of Systematic Reviews

6 July 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6483200&resulttype=core&format=json

14 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6483200&resulttype=core&format=json

14 May 2020

page(s)

CD002068

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6483200&resulttype=core&format=json

Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish-Swedish co-operative study group.

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Different doses of pamidronate in patients with painful osteolytic bone metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Pamidronate treatment in patients with malignant osteolytic bone disease and pain: a prospective randomized double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Controlled Clinical Study on the Use of Dichloromethylene Diphosphonate in Patients with Breast Carcinoma Metastasizing to the Skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Double-blind, placebo-controlled, dose-response trial of oral clodronate in patients with bone metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Palliation of painful bone metastases from prostate cancer using sodium etidronate: results of a randomized, prospective, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Bisphosphonate therapy in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Medical treatment of tumor-induced hypercalcemia and tumor-induced osteolysis: challenges for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Use of bisphosphonates in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Pain relief and quality-of-life assessment following intravenous and oral clodronate in hormone-escaped metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

The use of clodronate in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Oral clodronate in breast cancer patients with bone metastases: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Malignant bone pain: pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Clinical consequences of osteolytic bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Treatment of skeletal disease in breast cancer with clodronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Should bisphosphonates be standard therapy for bone pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Clodronate: the potential for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

High-dose intravenous pamidronate for metastatic bone pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Analgesic effect of bisphosphonates on bone pain in breast cancer patients: a review article

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Metabolic effects of pamidronate in patients with metastatic bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Use of bisphosphonates for the treatment of metastatic bone pain. A survey of palliative physicians in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Radiotherapy for painful bone metastases: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Patients' and nurses' ratings of pain and anxiety during burn wound care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002068

Markers of bone resorption in patients treated with pamidronate

21 January 2018

1 reference

12 December 2020

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group

1 reference

12 December 2020

The Emerging Role of Bisphosphonates in the Prevention of Bone Metastases

1 reference

12 December 2020

Bisphosphonates as cancer drugs

1 reference

12 December 2020

Pamidronate for the prevention of skeletal-related events in multiple myeloma. What does the public think it is worth?

1 reference

12 December 2020

Cost utility analysis of prophylactic pamidronate for the prevention of skeletal related events in patients with advanced breast cancer

1 reference

12 December 2020

[Bisphosphonates and bone metastases]

1 reference

12 December 2020

The effect of two different doses of oral clodronate on pain in patients with bone metastases

1 reference

12 December 2020

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials

1 reference

12 December 2020

Treatment of metastatic bone pain with Aredia(Pamidronate)

1 reference

12 December 2020

Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma

1 reference

12 December 2020

Effect of pamidronate on skeletal morbidity in myelomatosis. Part 1. The results of the first 12 months of pamidronate therapy

1 reference

12 December 2020

Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases--a prospective randomised placebo-controlled multicentre study

1 reference

12 December 2020

A double-blind, crossover trial of intravenous clodronate in metastatic bone pain

1 reference

12 December 2020

Effect of daily etidronate on the osteolysis of multiple myeloma

1 reference

12 December 2020

Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.

1 reference

12 December 2020

A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma

1 reference

12 December 2020

Treatment of skeletal disease in breast cancer: a controlled clodronate trial

1 reference

12 December 2020

Clodronate for osteolytic metastases due to breast cancer

1 reference

12 December 2020

Differences and similarities between patient and physician perceptions of patient pain

1 reference

12 December 2020

Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)

1 reference

12 December 2020

Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma

1 reference

12 December 2020

Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton

1 reference

12 December 2020

Use of Dichloromethylene Diphosphonate in Metastatic Bone Disease

1 reference

12 December 2020

Dichloromethylene diphosphonate in the treatment of lytic bone metastases

1 reference

12 December 2020

Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma

1 reference

12 December 2020

Biphosphonates as an adjunct to palliative therapy of bone metastases from prostatic carcinoma. A pilot study on clodronate

1 reference

12 December 2020

Pamidronate in the treatment of bone metastases: results of 2 dose-ranging trials in patients with breast or prostate cancer

1 reference

12 December 2020

Role of pamidronate in the management of bone metastases from breast cancer: results of a non-comparative multicenter phase II trial. Aredia Multinational Cooperative Group

1 reference

12 December 2020

Progress in the treatment and palliation of advanced breast cancer: does the dose of pamidronate determine its effects?

1 reference

12 December 2020

Effect of oral clodronate on metastatic bone pain: a double-blind, placebo-controlled study

1 reference

12 December 2020

Palliative pamidronate treatment in patients with bone metastases from breast cancer

1 reference

12 December 2020

Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial

1 reference

12 December 2020

Subgroup and cost-benefit analysis of the Finnish multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

1 reference

12 December 2020

Treatment of cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline alone

1 reference

12 December 2020

[Double-blind trial of oral clodronate in breast cancer patients with bone metastases]

1 reference

12 December 2020

Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia

1 reference

12 December 2020

Disodium pamidronate in the treatment of bone metastases from breast cancer

1 reference

12 December 2020

Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study

1 reference

12 December 2020

Treatment of multiple myeloma with etidronate: results of a multicentre double-blind study. Groupe d'Etudes et de Recherches sur le Myélome (GERM)

1 reference

12 December 2020

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

1 reference

12 December 2020

Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications

1 reference

12 December 2020

[Disodium pamidronate (APD) in the treatment of bone metastases]

1 reference

12 December 2020

Pamidronate infusions as single-agent therapy for bone metastases: a phase II trial in patients with breast cancer

1 reference

12 December 2020

The role of bisphosphonates in the treatment of bone metastases--the U.S. experience

1 reference

12 December 2020

Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients?

1 reference

12 December 2020

Pain management for bone metastases

1 reference

12 December 2020

Bisphosphonates for controlling pain from metastatic bone disease

1 reference

12 December 2020

Bisphosphonates in the treatment of bone diseases

1 reference

12 December 2020

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

Clodronate decreases the frequency of skeletal metastases in women with breast cancer

1 reference

12 December 2020

Pamidronate in the treatment of osteolytic bone metastases in breast cancer patients

1 reference

12 December 2020

Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy

1 reference

12 December 2020

Pyridinium cross-links in multiple myeloma: correlation with clinical parameters and use for monitoring of intravenous clodronate therapy--a pilot study of the German Myeloma Treatment Group (GMTG)

1 reference

12 December 2020

Efficacy of pamidronate in breast cancer with bone metastases: a randomized double-blind placebo controlled multicenter study

1 reference

12 December 2020

A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain

1 reference

12 December 2020

Subcutaneous clodronate: a study evaluating efficacy in hypercalcemia of malignancy and local toxicity

1 reference

12 December 2020

Bisphosphonates in multiple myeloma

1 reference

12 December 2020

Bisphosphonates and breast carcinoma

1 reference

12 December 2020

High dose pamidronate: clinical and biochemical effects in metastatic bone disease.

1 reference

12 December 2020

1 reference

12 December 2020

A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

1 reference

12 December 2020

The analgesic efficacy of clodronate compared with placebo in patients with painful bone metastases from prostatic cancer

1 reference

12 December 2020

Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease

1 reference

12 December 2020

Effects of the bisphosphonate olpadronate in patients with carcinoma of the prostate metastatic to the skeleton

1 reference

12 December 2020

Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer

1 reference

12 December 2020

Re: A randomized controlled trial of Intravenous clodronate

1 reference

12 December 2020

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

12 December 2020

A double blind randomized study of oral clodronate in the treatment of bone metastases from tumors poorly responsive to chemotherapy

1 reference

12 December 2020

Long-term oral pamidronate treatment inhibits osteoclastic bone resorption and bone turnover without affecting osteoblastic function in multiple myeloma

1 reference

12 December 2020

Bisphosphonates: lingering questions about their use

1 reference

12 December 2020

A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer

1 reference

12 December 2020

Aredia: the once-monthly infusion for the treatment of bone metastases

1 reference

12 December 2020

Role of pamidronate disodium in the treatment of metastatic bone disease

1 reference

12 December 2020

Current use of bisphosphonates in oncology. International Bone and Cancer Study Group

1 reference

12 December 2020

The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials

1 reference

12 December 2020

Diagnostic and prognostic value of biochemical markers in malignant bone disease: a prospective study on the effect of bisphosphonate on pain intensity and progression of malignant bone disease

1 reference

12 December 2020

The role of bisphosphonates for the treatment of bone disease in multiple myeloma

1 reference

12 December 2020

1 reference

12 December 2020

10.1002/14651858.CD002068

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6483200&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6483200&resulttype=core&format=json

14 May 2020

1 reference